Stephen Hagan
Pulmonary Disease · Wichita, KSNPI 1376569616
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.3% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $887 and has fallen 64.9% since, to $311 in 2023.
Across 178 payments — averaging $16.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$549
- GSK$535
- Mylan Specialty L.p.$367
- Actelion Pharmaceuticals US, Inc.$336
- United Therapeutics Corporation$223
- Bayer$200
- plus $685 from 15 others
What the payments were for
- Consulting fees$2007%
- Food & beverage$2,61490%
- Education$803%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 36 | $549 |
| GSK | 41 | $535 |
| Mylan Specialty L.p. | 26 | $367 |
| Actelion Pharmaceuticals US, Inc. | 16 | $336 |
| United Therapeutics Corporation | 13 | $223 |
| Bayer | 1 | $200 |
| Novartis | 11 | $146 |
| Grifols USA, LLC | 8 | $141 |
| Boehringer Ingelheim | 4 | $67 |
| Sunovion Pharmaceuticals Inc. | 4 | $55 |
| Regeneron Healthcare Solutions, Inc. | 3 | $53 |
| Baxter Healthcare | 2 | $37 |
| Pfizer | 2 | $34 |
| Mallinckrodt Hospital Products Inc. | 2 | $28 |
| Circassia Inc. | 2 | $26 |
| Genentech USA, Inc. | 1 | $22 |
| Electromed, Inc. | 2 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
| Advanced Respiratory, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Adempas$200
How this compares
$2,894 in reported general payments places this provider in the 55th percentile of 92 pulmonary disease providers in Kansas.
Other pulmonary disease in Wichita
- Abdel-Ghanie Abu-SamraWichita$60K
- Victor SalloumWichita$14K
- Ibrahim RaphaelWichita$13K
- Nader EldikaWichita$9K
- Dennis Oyieng'oWichita$9K
- Mark WencelWichita$9K
- John FlesherWichita$7K
- Youssef YammineWichita$6K
- Raid Abu-AwwadWichita$6K
- Maged El-ZeinWichita$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.